Trxade Group, Inc. Made Headway
Trxade Group, Inc. (MEDS:NASDAQ) shot up at $9.09, a gain of 119.6%. On Tue, Feb 20, 2024, MEDS:NASDAQ touched a New 2-Week High of $9.09. From Tue, Feb 06, 2024, the stock recorded 77.78% Up Days and 50.00% Green Days
The stock spiked on Tue, Feb 20, 2024 at $13.9 with a volume of 12M+.
About Trxade Group, Inc. (MEDS:NASDAQ)
Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.
Top 10 Gainers:
- Pop Culture Group Co. Ltd (CPOP:NASDAQ), 171.32%
- Trxade Group, Inc. (MEDS:NASDAQ), 119.57%
- Monopar Therapeutics Inc. (MNPR:NASDAQ), 96.65%
- Avinger, Inc. (AVGR:NASDAQ), 83.46%
- Vincerx Pharma Inc. (VINC:NASDAQ), 70.72%
- Shineco Inc. (SISI:NASDAQ), 56.46%
- Biofrontera Inc. (BFRI:NASDAQ), 53.44%
- F45 Training Holdings Inc. (FXLV:NYSE), 52.17%
- Quantum FinTech Acquisition Corporation (QFTA:NYSEMKT), 51.33%
- Quantum FinTech Acquisition Corporation (QFTA:NYSE), 51.33%